A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cheng, Li Jen ^a   Chen, Jeng Huei ^b   Lin, Ming Yen ^a,c   Chen, Li Chia ^c,d   Lao, Chun Huan ^e   Luh, Hsing ^b   Hwang, Shang Jyh ^a,f,g  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; DIABETES COMPLICATIONS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STROKE; TAIWAN; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TAIWAN; YOUNG ADULT;

EID: 84945921007     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15687     Document Type: Article

References (39)

1. Clarke, P. M. et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47, 1747-1759 (2004).
2. Fox, C. S. et al. Trends in cardiovascular complications of diabetes. JAMA 292, 2495-2499 (2004).
3. Morrish, N. J., Wang, S. L., Stevens, L. K., Fuller, J. H. and Keen, H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl 2, S14-21 (2001).
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36, 1033-1046 (2013).
5. Chan, J. C. et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301, 2129-2140 (2009).
6. Vinicor, F. The public health burden of diabetes and the reality of limits. Diabetes Care 21 Suppl 3, C15-18 (1998).
7. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 36 Suppl 1, S11-66 (2013).
8. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). (Royal College of Physicians, 2008).
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329, 977-986 (1993).
10. Woodward, M. et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 26, 360-366 (2003).
11. Kanaya, A. M. et al. Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE). Diabetes Care 34, 930-937 (2011).
12. Karter, A. J. et al. Ethnic disparities in diabetic complications in an insured population. JAMA 287, 2519-2527 (2002).
13. Khan, N. A. et al. Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care 34, 96-101 (2011).
14. Shah, B. R. et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care 36, 2670-2676 (2013).
15. Bhalla, V. et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 36, 1215-1221 (2013).
16. Hall, Y. N. et al. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68, 2310-2316 (2005).
17. Wu, A. Y. et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48, 17-26 (2005).
18. Li, Y., Liao, Y., Fan, A., Zhang, X. and Balluz, L. Asian American/Pacific Islander paradox in diabetic retinopathy: findings from the Behavioral Risk Factor Surveillance System, 2006-2008. Ethn Dis 20, 111-117 (2010).
19. Lanting, L. C., Joung, I. M., Mackenbach, J. P., Lamberts, S. W. and Bootsma, A. H. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care 28, 2280-2288 (2005).
20. Abbasi, A. et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ (Clinical research ed.) 345, doi: http://dx.doi.org/10.1136/bmj.e5900 (2012).
21. Putter, H., Fiocco, M. and Geskus, R. B. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26, 2389-2430 (2007).
22. Tappenden, P. et al. Using whole disease modeling to inform resource allocation decisions: economic evaluation of a clinical guideline for colorectal cancer using a single model. Value Health 16, 542-553 (2013).
23. Wolbers, M., Koller, M. T., Witteman, J. C. and Steyerberg, E. W. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology (Cambridge, Mass.) 20, 555-561 (2009).
24. Vanholder, R. et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20, 1048-1056 (2005).
25. Kissela, B. M. et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28, 355-359 (2005).
26. Witt, B. J. et al. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med 143, 785-792 (2005).
27. Elsayed, E. F. et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 167, 1130-1136 (2007).
28. Bang, H. et al. Validation and comparison of a novel screening guideline for kidney disease: KEEPing SCORED. Arch Intern Med 168, 432-435 (2008).
29. Bang, H. et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 167, 374-381 (2007).
30. Kshirsagar, A. V. et al. A simple algorithm to predict incident kidney disease. Arch Intern Med 168, 2466-2473 (2008).
31. National Collaborating Centre for Chronic Conditions. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. National Institute for Health and Clinical Excellence Clinical Guidance CG 73. (London, 2008).
32. Hambleton, I. R. et al. All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study. Diabetes Care 32, 306-307 (2009).
33. Resnick, H. E. et al. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care 27, 1286-1293 (2004).
34. Chang, R. E., Lin, S. P. and Aron, D. C. A pay-for-performance program in Taiwan improved care for some diabetes patients, but doctors may have excluded sicker ones. Health Aff (Millwood) 31, 93-102 (2012).
35. Chen, T. T., Chung, K. P., Lin, I. C. and Lai, M. S. The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program? Health Serv Res 46, 47-60 (2011).
36. Tan, E. C., Pwu, R. F., Chen, D. R. and Yang, M. C. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan? Qual Life Res 23, 687-696 (2014).
37. Chang, T.-J. et al. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: An analysis of the National Health Insurance database. Taiwan Yi Xue Hui Za Zhi 111, 605-616 (2012).
38. Cheng, C. L., Kao, Y. H., Lin, S. J., Lee, C. H. and Lai, M. L. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20, 236-242 (2011).
39. Chang, Y. T., Wu, J. L., Hsu, C. C., Wang, J. D. and Sung, J. M. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009. Diabetes Care 37, 277-285 (2014).